Meeting Two

Meeting two of the committee was held on July 19 - 21, 2005 at the National Academy of Sciences Building, 2101 Constitution Ave, NW (Entrance on C Street), Washington, D.C., Lecture Room.

• The meeting was open to the public on Tuesday, July 19th from 3:00pm - 6:00pm & Wednesday, July 20th from 1:00pm - 5:45pm.

To view the Agenda for this meeting, please click here. Available speaker PowerPoint slides from July 20th are now posted to the agenda page, under the speaker name. Available statements from the public comment session held on July 19th will be posted soon.

To view the Transcript from day one, July 19th, 2005, click here

To view the Transcript from day two, July 20, 2005, click here

• The committee was in closed session on Wednesday, July 20th from 8:00am - 1:00pm & Thursday, July 21st from 8:00am - 3:00pm.

The first day of the meeting (July 19th, 3:00 - 6:00pm) was devoted to hearing public statements.

IOM committees decide as their work progresses what meetings will be closed or open. The agendas for future meetings of this committee have not yet been determined, so it is not yet known when (or if) there will be another opportunity for public comment. As committee members deliberate, they decide when and how they need to gather further information. You can, of course, submit written statements or documents anytime during the committee process if you do not have an opportunity to speak.

If you have information that you would like to share with the committee (regardless of whether you also spoke at the meeting), or would like to supplement your talk with a longer written statement or other documentation, you can do so by submitting it to the committee by using the contact information below. **Please note** any comments that you submit to the committee, including your name and identifying information, will not be kept confidential and will be included in a Public Access File as the National Academy of Sciences complies with Section 15 of the Federal Advisory Committee Act (FACA). The National Academies shall be authorized to use any such comments or submissions in accordance with the National Academies' Terms of Use Statement.

To subscribe to the project listserv, please click here.

Contact Information:
Mailing Address:
Institute of Medicine
Keck Center, 8th Floor
Board on Population Health and Public Health Practice
Committee on Assessment of the U. S. Drug Safety System
500 5th Street, NW
Washington DC, 20001

Fax: 202/334-2939
E-mail: DrugSafety@nas.edu